| Literature DB >> 28978343 |
Mohsen Mazidi1,2, Andre Pascal Kengne3, Dimitri P Mikhailidis4, Peter P Toth5,6, Kausik K Ray7, Maciej Banach8,9,10.
Abstract
AIM: To investigate the association of major dietary patterns with glucose and insulin homeostasis parameters in a large American sample. The association between dietary patterns (DP) derived via principal components analysis (PCA), with glucose/insulin homeostasis parameters was assessed. The likelihood of insulin resistance (IR) across the DPs quarters was also explored.Entities:
Keywords: Dietary patterns; Glucose homeostasis; Insulin homeostasis; Insulin resistance
Mesh:
Substances:
Year: 2017 PMID: 28978343 PMCID: PMC5628497 DOI: 10.1186/s12944-017-0571-x
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Demographic characteristics of subjects
| Characteristics | Overall | Non-diabetic subjects | Diabetic subjects |
| |
|---|---|---|---|---|---|
| Sex | Men (%) | 48.9 | 48.4 | 53.1 | <0.001 |
| Women (%) | 51.1 | 51.6 | 46.9 | ||
| Age (Years) | 45.9 ± 0.2 | 46.1 ± 0.2 | 59.6 ± 0.3 | <0.001 | |
| Race/Ethnicity | White (non-Hispanic) (%) | 68.5 | 48.3 | 42.3 | <0.001 |
| Non-Hispanic Black (%) | 11.6 | 19.7 | 21.4 | ||
| Mexican-American (%) | 8.3 | 18.9 | 22.7 | ||
| Other Hispanic (%) | 5.0 | 8.5 | 8.5 | ||
| Other (%) | 6.6 | 4.6 | 5.0 | ||
| Marital Status | Married (%) | 50.2 | 51.4 | 55.4 | <0.001 |
| Widowed (%) | 8.8 | 7.5 | 15.1 | ||
| Divorced (%) | 10.2 | 9.9 | 12.3 | ||
| Never married (%) | 18.9 | 19.7 | 9.2 | ||
| Education Status | Less than high school (%) | 12.2 | 11.7 | 21.4 | <0.001 |
| Completed high school (%) | 39.0 | 39.8 | 41.8 | ||
| More than high school (%) | 48.8 | 48.5 | 36.7 | ||
| Body mass index (kg/m2) | 28.5 ± 0.1 | 28.4 ± 0.1 | 31.8 ± 0.2 | <0.001 | |
| Waist circumference (cm) | 98 ± 0.3 | 97 ± 1 | 107 ± 1 | <0.001 | |
| Anthropometrically predicted visceral adipose tissue | 179.9 ± 1.8 | 174.8 ± 2.3 | 249.2 ± 1.9 | <0.001 | |
| Serum triglycerides (mg/dl) | 154 ± 3 | 147 ± 3 | 215 ± 4 | <0.001 | |
| Serum total cholesterol (mg/dl) | 196 ± 1 | 190 ± 3 | 195 ± 2 | <0.001 | |
| Serum high density lipoprotein (mg/dl) | 53 ± 1.6 | 53 ± 2 | 47.1 ± 1 | <0.001 | |
| Serum TG/HDL ratio | 3.5 ± 0.1 | 3.3 ± 0.1 | 5.5 ± 0.7 | <0.001 | |
| Serum hsCRP (mg/dl) | 0.39 ± 0.05 | 0.40 ± 0.06 | 0.63 ± 0.02 | <0.001 | |
| Serum Apolipoprotein (B) (mg/dL) | 93 ± 2 | 95 ± 3 | 97 ± 2 | <0.001 | |
| Systolic blood pressure (mmHg) | 121 ± 1 | 122 ± 0.3 | 132 ± 1 | <0.001 | |
| Diastolic blood pressure (mmHg) | 70 ± 1 | 68 ± 0.4 | 70 ± 0.3 | <0.001 | |
| Fasting blood glucose (mg/dl) | 98 ± 0.1 | 91 ± 0.4 | 182 ± 1 | <0.001 | |
| Plasma Insulin (μU/mL) | 12.9 ± 0.1 | 12.7 ± 0.4 | 22.3 ± 0.1 | <0.001 | |
| HOMA-IR | 3.3 ± 0.08 | 2.9 ± 0.08 | 9.6 ± 0.06 | <0.001 | |
| HOMA-B | 15.6 ± 2.5 | 162.4 ± 3.6 | 85.5 ± 1.2 | <0.001 | |
| HOMA-S | 0.56 ± 0.01 | 0.60 ± 0.02 | 0.25 ± 0.01 | <0.001 | |
| HbA1c (%) | 5.5 ± 0.01 | 5.4 ± 0.01 | 7.4 ± 0.02 | <0.001 | |
| 2-h blood glucose (mg/dL) | 116 ± 1 | 117 ± 1 | 273 ± 0.3 | <0.001 | |
| TyG index | 8226 ± 72 | 6785 ± 83 | 20,590 ± 234 | <0.001 | |
| Lipid Accumulation Product | 68 ± 0.5 | 63 ± 0.2 | 112 ± 0.9 | <0.001 | |
| Visceral Adiposity Index | 2.5 ± 0.02 | 2.3 ± 0.03 | 4.0 ± 0.05 | <0.001 | |
Value are expressed as a mean and standard error of the mean (SEM) or percentage. HOMA-IR, Homeostatic model assessment of insulin resistance; HOMA-B, Homeostatic model assessment of β-cell function HOMA-S; Homeostatic model assessment of insulin sensitivity TyG index, triglyceride-glucose index hsCRP; high sensitivity C-reactive protein, HbA1c glycated haemoglobin, TG/HDL ratio; triglyceride to high density lipoprotein. P values are for the comparison between “Non-diabetic “and “Diabetic “subjects
Adjusted (age-, sex-, race-, C-reactive protein, smoking, physical activity) mean of glucose homeostasis factors across the quarters of the dietary patterns
| Character | First Dietary Pattern | Second Dietary Pattern | Third Dietary Pattern | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 |
| Q1 | Q2 | Q3 | Q4 |
| Q1 | Q2 | Q3 | Q4 |
| ||
| total | Fasting blood glucose (mg/dl) | 100 ± 1 | 101.6 ± 0.4 | 101.2 ± 0.5 | 102.5 ± 0.3 | 0.123 | 102.2 ± 0.1 | 101.8 ± 0.5 | 100.2 ± 0.5 | 99.1 ± 0.7 | <0.001 | 100.5 ± 0.3 | 100.6 ± 0.4 | 101.1 ± 0.3 | 102.4 ± 0.4 | <0.001 |
| Plasma Insulin (μU/mL) | 12.3 ± 0.3 | 13.5 ± 0.5 | 14.6 ± 0.4 | 15.5 ± 0.2 | <0.001 | 14.5 ± 0.3 | 14.0 ± 0.2 | 13.2 ± 0.4 | 12.7 ± 0.6 | <0.001 | 12.1 ± 0.3 | 13.2 ± 0.7 | 14.0 ± 0.3 | 14.2 ± 0.2 | <0.001 | |
| HbA1c (%) | 5.6 ± 0.01 | 5.7 ± 0.01 | 5.7 ± 0.03 | 5.8 ± 0.06 | <0.001 | 5.8 ± 0.01 | 5.7 ± 0.01 | 5.6 ± 0.01 | 5.4 ± 0.02 | <0.001 | 5.6 ± 0.03 | 5.6 ± 0.04 | 5.7 ± 0.04 | 5.7 ± 0.05 | <0.001 | |
| 2 h–Glu (mg/dl) | 121.5 ± 1.4 | 118.8 ± 1.2 | 121.4 ± 1.7 | 122.8 ± 1.6 | 0.526 | 123.1 ± 1.2 | 122.5 ± 1.3 | 119.2 ± 1.7 | 115.4 ± 1.9 | <0.001 | 120.4 ± 1.4 | 119.1 ± 1.7 | 119.5 ± 1.1 | 120.0 ± 1.2 | 0.109 | |
| HOMA-IR | 3.3 ± 0.1 | 3.5.9 ± 0.1 | 3.8 ± 0.1 | 4.1 ± 0.1 | <0.001 | 3.9 ± 0.2 | 3.7 ± 0.1 | 3.6 ± 0.1 | 3.3 ± 0.1 | <0.001 | 3.4 ± 0.1 | 3.4 ± 0.1 | 3.7 ± 0.1 | 3.9 ± 0.1 | <0.001 | |
| HOMA-B | 143.5 ± 5.1 | 144.5 ± 2.6 | 160.2 ± 6.5 | 164.7 ± 4.2 | <0.001 | 150 ± 2.6 | 153.1 ± 3.8 | 158.7 ± 4.1 | 150.4 ± 2.9 | 0.415 | 147.6 ± 4.1 | 148.0 ± 8.2 | 163.1 ± 6.3 | 151.1 ± 4.1 | 0.225 | |
| HOMA-S | 0.58 ± 0.01 | 0.55 ± 0.06 | 0.46 ± 0.01 | 0.49 ± 0.02 | <0.001 | 0.50 ± 0.01 | 0.51 ± 0.09 | 0.54 ± 0.03 | 0.58 ± 0.04 | <0.001 | 0.54 ± 0.05 | 0.53 ± 0.04 | 0.52 ± 0.01 | 0.54 ± 0.02 | 0.125 | |
| TyG index | 8199.9 ± 180.2 | 8578.7 ± 213.6 | 8716.8 ± 215.2 | 8835.8 ± 231.4 | 0.415 | 8415.4 ± 232.3 | 8718.4 ± 192.6 | 8753.6 ± 178.2 | 8356.3 ± 192.3 | 0.102 | 8365.2 ± 235.1 | 8424.8 ± 241.3 | 8611.0 ± 202.2 | 8833.9 ± 210.3 | <0.001 | |
| Visceral Adiposity Index | 2.2 ± 0.02 | 2.4 ± 0.03 | 2.5 ± 0.07 | 2.7 ± 0.06 | <0.001 | 2.6 ± 0.05 | 2.5 ± 0.01 | 2.4 ± 0.06 | 2.1 ± 0.09 | <0.001 | 2.6 ± 0.04 | 2.5 ± 0.06 | 2.6 ± 0.01 | 2.6 ± 0.08 | 0.324 | |
| Lipid Accumulation Product | 63.2 ± 1.5 | 66.3 ± 2.0 | 70.5 ± 1.9 | 73.8 ± 1.6 | <0.001 | 70.6 ± 1.7 | 69.4 ± 2.0 | 68.6 ± 1.3 | 62.8 ± 2.8 | <0.001 | 64.4 ± 1.4 | 65.6 ± 1.0 | 69.1 ± 1.6 | 70.0 ± 1.3 | <0.001 | |
| Without DM | Fasting blood glucose (mg/dl) | 91.3 ± 0.3 | 91.6 ± 0.4 | 92.4 ± 0.6 | 91.1 ± 0.4 | 0.325 | 92.9 ± 0.3 | 91.1 ± 0.2 | 91.2 ± 0.4 | 90.8 ± 0.3 | <0.001 | 90.1 ± 0.7 | 91.7 ± 0.4 | 91.8 ± 0.2 | 91.1 ± 0.3 | 0.724 |
| Plasma Insulin (μU/mL) | 12.1 ± 0.2 | 12.3 ± 0.1 | 13.0 ± 0.09 | 14.0 ± 0.1 | <0.001 | 13.5 ± 0.1 | 13.0 ± 0.1 | 12.6 ± 0.1 | 12.4 ± 0.1 | <0.001 | 12.1 ± 0.1 | 12.9 ± 0.1 | 13.1 ± 0.1 | 13.6 ± 0.0 | <0.001 | |
| HbA1c (%) | 5.4 ± 0.01 | 5.4 ± 0.01 | 5.4 ± 0.02 | 5.4 ± 0.03 | 0.725 | 5.5 ± 0.02 | 5.5 ± 0.01 | 5.4 ± 003 | 5.3 ± 0.01 | <0.001 | 5.4 ± 0.01 | 5.4 ± 0.02 | 5.4 ± 0.01 | 5.4 ± 0.01 | 0.415 | |
| 2 h–Glu (mg/dl) | 117.1 ± 0.1 | 113.1 ± 1.2 | 113.3 ± 1.2 | 114.5 ± 1.3 | 0.623 | 116.4 ± 1.7 | 115.8 ± 1.4 | 113.7 ± 1.2 | 111.1 ± 1.4 | <0.001 | 114.4 ± 2.0 | 113.6 ± 1.3 | 115.4 ± 2.0 | 114.2 ± 1.8 | 0.328 | |
| HOMA-IR | 2.8 ± 0.1 | 2.9 ± 0.1 | 3.0 ± 0.2 | 3.3 ± 0.1 | <0.001 | 3.1 ± 0.1 | 3.0 ± 0.1 | 2.9 ± 0.1 | 2.6 ± 0.1 | <0.001 | 2.6 ± 0.1 | 2.7 ± 0.1 | 3.1 ± 0.09 | 3.2 ± 0.1 | <0.001 | |
| HOMA-B | 146.6 ± 2.6 | 148.9 ± 3.2 | 167.0 ± 5.6 | 173.0 ± 3.4 | <0.001 | 155.9 ± 2.8 | 158.4 ± 3.4 | 150.2 ± 2.6 | 155.7 ± 4.6 | 0.415 | 152.8 ± 2.3 | 151.6 ± 4.1 | 170.1 ± 3.2 | 151.0 ± 2.1 | 0.462 | |
| HOMA-S | 0.56 ± 0.01 | 0.59 ± 0.02 | 0.56 ± 0.06 | 0.54 ± 0.01 | <0.001 | 0.50 ± 0.01 | 0.53 ± 0.01 | 0.60 ± 0.02 | 0.62 ± 0.04 | <0.001 | 0.55 ± 0.03 | 0.58 ± 0.01 | 0.55 ± 0.01 | 0.60 ± 0.02 | 0.328 | |
| TyG index | 6592.3 ± 123.5 | 6970.9 ± 182.3 | 7189.9 ± 142.6 | 7289.8 ± 172.3 | <0.001 | 7025.6 ± 145.9 | 6937.6 ± 122.5 | 7156.9 ± 147.6 | 6856.4 ± 176.3 | 0.109 | 6974.3 ± 134.5 | 6979.2 ± 138.6 | 7060.8 ± 174.3 | 6961.2 ± 162.9 | 0.715 | |
| Lipid Accumulation Product | 2.2 ± 0.08 | 2.4 ± 0.04 | 2.5 ± 0.06 | 2.6 ± 0.01 | <0.001 | 2.2 ± 0.05 | 2.1 ± 0.09 | 2.0 ± 0.04 | 1.8 ± 0.06 | <0.001 | 2.4 ± 0.04 | 2.4 ± 0.06 | 2.3 ± 0.04 | 2.4 ± 0.08 | 0.136 | |
| Visceral Adiposity Index | 57.0 ± 2.3 | 61.2 ± 1.0 | 67.5 ± 2.0 | 69.4 ± 1.4 | <0.001 | 65.6 ± 2.8 | 62.4 ± 1.4 | 61.6 ± 2.0 | 58.4 ± 1.9 | <0.001 | 60.4 ± 1.8 | 61.1 ± 1.4 | 64.1 ± 2.0 | 65.5 ± 1.7 | <0.001 | |
Analysis of covariance conducted to estimate the adjusted means. Value are expressed as a mean and standard error of the mean (SEM) or percentage. HOMA-IR, Homeostatic model assessment of insulin resistance; HOMA-B, Homeostatic model assessment of β-cell function HOMA-S; Homeostatic model assessment of insulin sensitivity, TyG index, triglyceride-glucose index hsCRP; high sensitivity C-reactive protein, HbA1c glycated haemoglobin